NEW YORK (GenomeWeb) – Mesa Biotech announced today that it has received CE marking for its molecular diagnostic assay to detect respiratory syncytial virus (RSV). The point-of-care test will now be will marketed by select distributors in the EU.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.
The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.
A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.
In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.
This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.
This webinar will overview the potential for liquid biopsy approaches to monitor therapy resistance in lung cancer.
This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.
This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).